Skip to content

ANESTEPSY: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ANESTEPSY

BE 0466.008.883
NACE 86.220, Specialist medical practice
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€9,348
2024 · €5,512-€14,860
Equity
€99,026
2024 · €108,374-€9,348
Cash
€57,811
2024 · €54,563+€3,248
Balance sheet total
€101,890
2024 · €119,648-€17,759

Largest movements

2024 to 2025
Assets
  • Receivables after one year -€18,547

    no longer reported in 2025 (was €18,547)

  • Receivables within one year -€4,688

    down €4,688 (-12.4%), from €37,725 to €33,037

    of which Trade receivables: -€32,488

  • Cash +€3,248

    up €3,248 (+6.0%), from €54,563 to €57,811

    mainly Receivables after one year (+€18,547) and Receivables within one year (+€4,688)

  • Tangible fixed assets +€2,147

    up €2,147 (+37.8%), from €5,688 to €7,835

    of which Furniture and vehicles: +€3,958

Equity and liabilities
  • Profit (loss) carried forward -€9,348

    down €9,348 (-33.3%), from €28,035 to €18,687

  • Tax, wage and social debts -€8,827

    no longer reported in 2025 (was €8,827)

Income statement
  • Gross operating margin -€23,014

    down €23,014, from €21,230 to -€1,784

  • Other operating charges -€4,912

    down €4,912 (-87.4%), from €5,622 to €710

  • Taxes -€3,630

    down €3,630 (-94.9%), from €3,825 to €195

  • Depreciation +€631

    up €631 (+27.9%), from €2,264 to €2,895

  • Financial charges -€264

    down €264 (-6.5%), from €4,053 to €3,789

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €5,512
Gross operating margin -€23,014
Depreciation -€631
Other operating charges +€4,912
Financial income -€20
Financial charges +€264
Taxes +€3,630
Result 2025 -€9,348
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€8,290
Investment -€5,042
Financing €0
Cash 2024 €54,563
Net result for the year -€9,348
Depreciation +€2,895
Receivables after one year +€18,547
Receivables within one year +€4,688
Deferred charges and accrued income -€81
Trade debts +€265
Tax, wage and social debts -€8,827
Accrued charges and deferred income +€150
Investment in fixed assets (net) -€5,042
Cash 2025 €57,811
brings cash intakes cash out
Every line side by side 39 lines
Line Code 2024 2025 Change %
Total assets 20/58 €119,648 €101,890 -€17,759 -14.8%
Fixed assets 21/28 €5,688 €7,835 +€2,147 +37.8%
Tangible fixed assets 22/27 €5,688 €7,835 +€2,147 +37.8%
Land and buildings 22 €95 - -€95
Plant, machinery and equipment 23 €3,530 €1,815 -€1,715 -48.6%
Furniture and vehicles 24 €2,062 €6,020 +€3,958 +192%
Current assets 29/58 €113,961 €94,054 -€19,906 -17.5%
Amounts receivable after more than one year 29 €18,547 - -€18,547
Other amounts receivable 291 €18,547 - -€18,547
Amounts receivable within one year 40/41 €37,725 €33,037 -€4,688 -12.4%
Trade receivables 40 €32,801 €314 -€32,488 -99.0%
Other amounts receivable 41 €4,923 €32,723 +€27,800 +565%
Cash at bank and in hand 54/58 €54,563 €57,811 +€3,248 +6.0%
Deferred charges and accrued income 490/1 €3,125 €3,207 +€81 +2.6%
Total equity and liabilities 10/49 €119,648 €101,890 -€17,759 -14.8%
Equity 10/15 €108,374 €99,026 -€9,348 -8.6%
Contributions 10/11 €18,608 €18,608 = 0.0%
Reserves 13 €61,731 €61,731 = 0.0%
Distributable reserves 133 €61,731 €61,731 = 0.0%
Profit (loss) carried forward 14 €28,035 €18,687 -€9,348 -33.3%
Amounts payable 17/49 €11,275 €2,863 -€8,411 -74.6%
Amounts payable within one year 42/48 €11,275 €2,713 -€8,561 -75.9%
Trade debts 44 €2,448 €2,713 +€265 +10.8%
Suppliers 440/4 €2,448 €2,713 +€265 +10.8%
Taxes, remuneration and social security 45 €8,827 - -€8,827
Taxes 450/3 €8,827 - -€8,827
Accrued charges and deferred income 492/3 - €150 +€150
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,264 €2,895 +€631 +27.9%
Other operating charges 640/8 €5,622 €710 -€4,912 -87.4%
Gross operating margin 9900 €21,230 -€1,784 -€23,014
Operating profit (loss) 9901 €13,344 -€5,389 -€18,733
Financial income 75/76B €46 €26 -€20 -44.3%
Recurring financial income 75 €46 €26 -€20 -44.3%
Financial charges 65/66B €4,053 €3,789 -€264 -6.5%
Recurring financial charges 65 €4,053 €3,789 -€264 -6.5%
Profit (loss) for the period before taxes 9903 €9,337 -€9,153 -€18,489
Income taxes 67/77 €3,825 €195 -€3,630 -94.9%
Profit (loss) for the period 9904 €5,512 -€9,348 -€14,860
Profit (loss) for the period to be appropriated 9905 €5,512 -€9,348 -€14,860

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.